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a b s t r a c t
Only a fewvaccines are commercially available against intestinal infections since the induction of a protec-
tive intestinal immune response is difﬁcult to achieve. For instance, oral administration of most proteins
results in oral tolerance instead of an antigen-speciﬁc immune response. We have shown before that
as a result of oral immunization of piglets with F4 ﬁmbriae puriﬁed from pathogenic enterotoxigenic
Escherichia coli (ETEC), the ﬁmbriae bind to the F4 receptor (F4R) in the intestine and induce a protective
F4-speciﬁc immune response. F4 ﬁmbriae are very stable polymeric structures composed of some minor





experiments identiﬁed FaeG amino acids 97 (N to K) and 201 (I to V) as determinants for F4 polymeric
stability. The interaction between the FaeG subunits inmutant F4 ﬁmbriae is reduced but bothmutant and
wild type ﬁmbriae behaved identically in F4R binding and showed equal stability in the gastro-intestinal
lumen. Oral immunization experiments indicated that a higher degree of polymerisation of the ﬁmbriae
in the intestine was correlated with a better F4-speciﬁc mucosal immunogenicity. These data suggest that















The default response against orally administered soluble anti-
ens is the induction of oral tolerance [1,2]. However, oral
dministration of F4 ﬁmbriae puriﬁed from F4+ enterotoxigenic
scherichia coli (ETEC) to piglets expressing an F4-speciﬁc recep-
or (F4R) on their intestinal epithelium, results in the induction of
protectivemucosal immune response [3]. Therefore, this F4model
anbeused to study the requirements of a soluble antigen to induce
mucosal immune response following oral administration [4].
ETEC bind with their ﬁmbriae to speciﬁc receptors present in
he intestine of man or animals, subsequently colonise the small
ntestine and induce diarrhoea in their host by secreting heat
abile (LT) and heat stable (ST) enterotoxins [5]. The type of ﬁm-
riae expressed by ETEC bacteria determines their host speciﬁcity.
ver twenty different ﬁmbriae are identiﬁed on human isolates
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6], whereas porcine ETEC isolates express 5 different ﬁmbriae
f which F4 and F18 are most prevalent [7]. F4+ and F18+ ETEC
nduce neonatal and post-weaning diarrhoea in piglets worldwide.
he interaction between the ﬁmbriae and their speciﬁc receptor in
he intestine is an essential step in the pathogenesis since piglets
hich do not express the F4-receptor (F4-receptor negative; F4R−)
r the F18-receptor are resistant to F4+ or F18+ ETEC infections
8,9]. Binding of puriﬁed F4 ﬁmbriae to the F4R is also impor-
ant in its mucosal immunogenicity, since no F4-speciﬁc immune
esponse is observed following oral administration of puriﬁed F4
mbriae in F4R− pigs [3]. However, binding of the ﬁmbrial antigens
o its intestinal receptor is not enough to induce an antigen-speciﬁc
ucosal immune response. Oral immunization of F18R+ pigs with
uriﬁed F18 ﬁmbriae, even in the presence of a mucosal adjuvant
r encapsulated to increase the stability in the gastro-intestinal
ract, did not result in an (protective) immune response [10,11].
oreover, it was shown that conjugation of antigen to cholera
oxin B, an analogue of LT-B, enables them to bind to GM1 on the
ntestinal surface and dramatically reduces the amount of antigen
eeded for tolerance induction [12]. Therefore, additional factors
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mmunogenicityof solublenon-replicatingantigens likepuriﬁedF4
mbriae.
In most ﬁmbrial systems, the adhesin is a highly conserved
inor subunit present at the tip. The ﬁmbrial structure is mainly
omposed of the less conserved major subunit, which may be a
ay to reduce cross-protection between different isolates since
arenteral immunization with puriﬁed ﬁmbriae showed mainly
ntibodies against the major subunit [13,14]. In contrast, the F4
mbrial adhesin FaeG is also the major ﬁmbrial subunit and is
ighly conserved within each of the three F4 serotypes ab, ac and
d [15,16]. So, this structural difference between F4 and most other
mbriae can be at least one of the causes of its mucosal immuno-
enicity. Indeed, puriﬁed F4 ﬁmbriae of strain GIS26 (F4GIS26) are
xpected to reach the small intestine in apolymeric shape following
ral administration since they pass the stomach before complete
egradation will happen [17]. We have previously shown that oral
mmunization with non-polymeric F4 ﬁmbrial FaeG adhesins was
ess efﬁcient in the induction of a mucosal F4-speciﬁc immune
esponse than immunization with polymeric F4 ﬁmbriae but were
nable to analyze the role of F4 ﬁmbrial stability on its immuno-
enicity [18,19].
In a previous study with 22 F4+ ETEC isolates, puriﬁed F4 ﬁm-
riae from 21 isolates showed a characteristic ladder pattern of
aeG polymers on SDS-PAGE without heating the samples [16].
nly ﬁmbriae puriﬁed fromstrain 5/95 (F45/95)were less stable and
ppeared as FaeG monomers. The aim of this study was to identify
he amino acids involved in the polymeric nature of F4 and to ana-
yze whether the polymeric nature of the ﬁmbriae was important
n regard to its mucosal immunogenicity.
. Materials and methods
.1. Wild type strains
GIS26 and 5/95 are both F4ac+ ETEC strains (Table 1), but their
4 ﬁmbriae have a different stability since they show a polymeric
nd monomeric band pattern respectively on a Coomassie stained
DS-PAGE without heat treatment of the samples. Interestingly,
he FaeG amino acid sequence differs at 7 positions between both
trains [16]. Five of these different amino acids present in FaeG
f strain 5/95 (FaeG5/95) were also found in the FaeG amino acid
equence of other F4+ E. coli ﬁeld isolates with ﬁmbriae show-
ng a polymeric pattern on a Coomassie stained SDS-PAGE without







acterial strains and plasmids
TEC strains
ame Description
/95 Wild type F4 ETEC strain with weak F4 ﬁmbriae (O149
IS26 Wild type F4 ETEC reference strain (O149:F4ac+LT+, ST
IS26faeG::Cm F4 deﬁcient mutant GIS26
IS26faeG::Cm (pJJJ89) GIS26faeG::Cm transformed with pJJJ89 to complemen
IS26faeG::Cm (pJJJ92) GIS26faeG::Cm transformed with pJJJ92 to complemen
IS26faeG::Cm (pHMM01) GIS26faeG::Cm transformed with pHMM01 to comple
IS26faeG::Cm (pHMM02) GIS26faeG::Cm transformed with pHMM02 to comple
IS26faeG::Cm (pHMM05) GIS26faeG::Cm transformed with pHMM05 to comple
lasmids
ame Description
JJJ88 Suicide vector carrying faeG::Cm and pir-dependent RK6 repl
JJJ89 FaeGGIS26 expression vector
JJJ92 FaeG5/95 expression vector
HMM01 FaeGGIS26 I201-V expression vector
HMM02 FaeGGIS26 I201-V, N97-K expression vector
HMM05 FaeGGIS26 N97-K expression vector6 (2008) 5728–5735 5729
ere only detected in FaeG5/95 and their inﬂuence on the F4 poly-
eric nature is analyzed in the present study by mutagenesis. The
acteria expressing wild type and mutant ﬁmbriae were cultured
vernight at 37 ◦C in Luria Broth-media or on LB-agar plates with
uitable antibiotic selection. For the villous adhesion assay or to
urify F4 ﬁmbriae, ETEC strains were cultured during 18h in Tryp-
one Soya Broth (Oxoid, Basingstoke, Hampshire, England) at 37 ◦C
nd 85 rpm.
.2. Construction of GIS26faeG::Cm
A mutant GIS26 ETEC strain, in which the F4 assembly is
locked by shutting down the gene encoding the major subunit
aeG, was created. Brieﬂy, 4.1 kb fragment of GIS26 F4 operon
as ampliﬁed by PCR (primers: 5′caaggatcctaaccgggtgacaaaagcac
nd 5′ccatctagaactcaatacttaccggcagtg), a 3.6 kb Cm-cassette from
HP45 cm [20] was cloned to SacI site in the middle of the faeG
ene, andﬁnally introduced into the suicideplasmid vector pGP704
21] to construct pJJJ88 (Fig. 1A). The plasmid pJJJ88 containing
he faeG::Cm was conjugated to GIS26 and the mutant allele was
ecombined into the chromosome by homologous recombination.
etRCmRAmpS colonies were screened to generate GIS26faeG::Cm.
hepresenceof faeG::CmwasconﬁrmedbyDNAhybridizationanal-
sis. Brieﬂy, 2.5mg PstI-digested bacterial DNA was separated on
garose gel, blotted onto nitrocellulose membrane, and hybridized
ith dioxygenin-labelled 0.8 kb faeG PCR-fragment (primers:
′tggatgactggtgatttc and 5′tcagtaataagttattgctac) (Fig. 1B).
.3. Complementation of GIS26faeG::Cm
The expression of F4 ﬁmbriae in GIS26faeG::Cm was restored
y introducing an expression vector containing an intact faeG gene
Table 1). Brieﬂy, a 1.0 kb faeG fragment including the periplasm
argeting signal sequence was ampliﬁed by PCR from ETEC strains
IS26 or 5/95 (primers: 5′caaggtaccggatagttttacggtaattcc and
′ccaggatccttagtaataagttattgctacgt) and cloned into KpnI site in
Blueskript II KS-(Stratagene, La Jolla, CA) under the control of
he lacZ-promoter (pJJJ89 and pJJJ92 respectively). The expression
ectors were introduced to GIS26faeG::Cm by conjugation under
mpicillin selection. The amino acids K97 and V201 which have
een detected only in FaeG5/95, were introduced in FaeGGIS26 to
nalyze their inﬂuence on the polymeric nature of F4 ﬁmbriae.
oint mutations were introduced in pJJJ89 by using a QuickChange





t F4 synthesis with wild type faeG sequence of strain GIS26 Tet, Cm, Amp
t F4 synthesis with wild type faeG sequence of strain 5/95 Tet, Cm, Amp
ment F4 synthesis Tet, Cm, Amp
ment F4 synthesis Tet, Cm, Amp
ment F4 synthesis Tet, Cm, Amp
Selection Host strain
icon Cm, Amp SM10pir





5730 F. Verdonck et al. / Vaccine 2
Fig. 1. Generation of the F4-deﬁcient GIS26faeG::Cm ETEC strain. (A) The F4 assem-












































































BCm-gene cassette. (B) DNA hybridization analysis of PstI-digested DNA from
IS26faeG::Cm clones with faeG probe. Lanes 1–4, CmRAmpR clones containing both
aeG::Cm and WT faeG; lanes 5–11, CmRAmpS clones containing only faeG::Cm lane
2, WT GIS26 faeG.
rotocol (Stratagene, La Jolla, CA). FaeGGIS26 N97 was changed to K
pHMM05) with primers 5′ctgtagtactcagaaaacctgatggtgaaacta
nd 5′tagtttcaccatcaggttttctgagtactacag and I201 to V
pHMM01) with primers 5′gagtaaacgcaaatgttacttctcttg and
′caagagaagtaacatttgcgtttactc. A ﬁnal plasmid was constructed
ith bothmutations (pHMM02). The introducedmutations and the
bsence of unintended mutations were conﬁrmed by sequencing.
.4. Puriﬁcation, gel- and ELISA analysis of F4 ﬁmbriae
F4 ﬁmbriae were puriﬁed from wild type and mutant strains
s described previously [17]. The protein concentration of puri-
ed F4 was determined using the bicinchoninic acid reaction with
ovine serum albumin as a standard (ICN Biomedicals, Belgium).
DS-PAGE (10%)wasused to analyze thepolymericnatureof F4ﬁm-
riae since unboiled F4GIS26 results in a ladder pattern consisting
f FaeG polymers and boiled F4GIS26 results only in the monomeric
aeG band [16]. The native gels (5%) and running buffer were pre-
ared as before [22], but in the absence of SDS and FaeG-speciﬁc
mmunoblotting was performed as previously [23]. A sandwich
LISA based on the FaeG-speciﬁc monoclonal antibodies (MAb)
MM01or IMM09was used to conﬁrm themonomeric or polymeric
ature of puriﬁed F4 sinceMAb IMM01 recognizes bothmonomeric
nd polymeric F4 ﬁmbriae [24] and theMAb IMM09 (also produced
n our laboratory) only recognising polymeric F4 ﬁmbriae..5. Electron microscopy
Puriﬁed F4 ﬁmbriae were treated by negative staining and visu-
lized by transmission electronmicroscopy as describedpreviously






n carbon and pioloform coated grids, stained with 2% uranylac-
tate in water and visualized using a Technai Spirit transmission
lectron microscope (FEI, Eindhoven, The Netherlands) operating
t 120kV. Micrographs were made using a bottom-mounted 4×4
Eagle camera (FEI).
.6. In vitro villous adhesion and inhibition assay
The F4R+ status of the immunized piglets was conﬁrmed by
ncubating small intestinal villi with F4+ ETEC strain GIS26 as
escribed previously [17]. Adhesion of more than 5 bacteria per
50m villous length was noted as positive [26]. The F4R-binding
apacity of wild type and mutant F4 ﬁmbriae was analyzed by an in
itro villous adhesion inhibition assay [17]. The test was done with
illi of three F4R+ and two F4R− pigs. The percentage inhibition of
dhesion was calculated for each sample by comparing with F4R+
illi incubated only with F4+ E. coli.
.7. Stability of F4 ﬁmbriae in gastro-intestinal conditions
Puriﬁed F4 ﬁmbriae (0.5mg/ml) were exposed to pepsin (Sigma
-7000, 0.16% (w/v)) digestion at pH 7.4, 4, 3, 2, or 1.5 for 30min
t 37 ◦C. The digestions were quenched by raising the pH over 8 by
dding Na2CO3 to a ﬁnal concentration of 45mM, and 4.5g of F4
as analyzed on native-PAGE and FaeG-speciﬁc immunoblotting
as performed as described previously [23].
Three piglets of 5 weeks (1 week following weaning) were
uthanized and luminal content was sampled from the stomach,
uodenum, jejunum, ileum and gall bladder. The samples were
entrifuged (10min, 500× g, 18 ◦C) and the supernatant was col-
ected. F4 ﬁmbriae (10g/ml) were immediately incubated in the
ollected supernatant at 37 ◦C for 0, 30, 60, 120 and 240min. Then,
erial dilutions of these samples were made and directly analyzed
n an F4-speciﬁc ELISA using the MAb IMM01 [18,24].
.8. Oral immunization experiment
All experimental and animal management procedures have
een approved by the animal care and ethics committee of the
aculty of Veterinary Medicine, Ghent University.
Eighteen, F4R+ and F4-seronegative conventionally bred pigs
Belgian Landrace×Piétrain)wereweaned at the age of 3–4weeks,
ransported to the experimental facilities at the faculty and subse-
uently housed in isolation units where they obtained water and
ood ad libitum. These piglets were treated orally with colistine
150,000U/kg of body weight/day, Promycine pulvis, VMD, Beren-
onk, Belgium) from 2 days before till 3 days after weaning to
revent E. coli infections due to transport and handling.
One week post weaning, pigs were orally immunized on three
uccessive days (days 0, 1 and 2) with 2mg puriﬁed wild type F4
mbriae (F4GIS26 group, n=6) derived from strain GIS26 or 2mg
uriﬁed mutant F4 ﬁmbriae (F4pHMM02 group, n=6) derived from
train GIS26faeG::Cm(pHMM02) diluted in 10ml PBS. Six animals
eceived PBS (PBS group) and served as negative control group. All
nimals were deprived of food and water from 3h before till 2 h
fter immunization.
One week following the oral immunization (day 8), three pigs
f each group were euthanized by intravenous injection of pen-
obarbital (24mg/kg; Nembutal, Sanoﬁ Santé Animale, Brussels,
elgium) and subsequent exsanguination in order to determine the
ntestinal F4-speciﬁc immune response. F4-speciﬁc IgA and IgM
ntibodies were determined in duodenal, jejunal and ileal con-
ents using the F4-speciﬁc ELISA and the F4-speciﬁc IgM, IgA and
gG antibody-secreting cells (ASCs) were enumerated in mesen-
eric lymph nodes (MLN), jejunal and ileal Peyer’s patches (JPP and






















































Fig. 2. Immunoblot analysis of puriﬁed wild type and mutant F4 ﬁmbriae under
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PP) and jejunal lamina propria (LP) [3]. Tissues and intestinal con-
ent were sampled following euthanasia of animals. Subsequently,
onomorphonuclear cells (MC) were isolated from MLN, JPP and
PP as previously described [27]. In addition, MC were isolated
rom a mid jejunal intestinal segment without Peyer’s patches
LP). After washing with PBS, the serosa and muscle layer of the
ntestinal fragment were removed. The tissue was cut into small
ieces and incubated three times for 40min in Hanks buffered
alt solution with 0.94mol/l DTT, 2.52mol/l kestranal (EDTA),
00g/ml penicillin–streptomycin in a shaking incubator at 37 ◦C.
he intestinal fragments were sieved, rinsed with Hanks buffered
alt solution and incubated 30min in RPMI with 5% FCS, 20mM
EPES, 0.1mg/ml DNAse and 100g/ml penicillin–streptomycin.
ubsequently, the tissue fragments were incubated 1h in the RPMI
olution with 0.36mg/ml collagenase in a shaking incubator at
7 ◦C. Then, the cell clumps were removed by ﬁltration through
70m cell strainer. The obtained MC from the different tissues
ere washed and resuspended at 107 cells/ml [27].
Two weeks after the oral immunizations (day 15), the remain-
ng animals received an intramuscular booster immunization with
00g puriﬁed F4GIS26 ﬁmbriae in incomplete Freunds adjuvant as
escribed previously [28]. Blood was taken from the vena jugularis
t days 0, 7, 15, 20, 24 and 29 to analyze F4-speciﬁc antibodies using
he F4-speciﬁc ELISA. At day 29, the remaining pigs were eutha-
ized. Jejunal villiwere isolatedof all euthanizedpigs toconﬁrmthe
resence of F4R by performing the in vitro villous adhesion assay.
.9. F4-speciﬁc antibodies and antibody secreting cells (ASC)
For detection of F4-speciﬁc antibodies, the previously described
ndirect ELISAwasused [3]. The IgM, IgAand IgGcut-off valueswere
alculated as themeanOD405-value of all sera (dilution 1/10) at day
, increased with 3 times the standard deviation. In case of intesti-
al contents, the IgA and IgM cut-off values were the OD405-values
f the dilution buffer, increased with 3 times the standard devia-
ion. The F4-speciﬁc antibody titer was the inverse of the highest
ilution that still had an OD405 higher than the calculated cut-off
alue.
F4-speciﬁc IgM, IgA and IgGASCweredetected as describedpre-
iously [3]. For each MC suspension, spots in 5 wells (106 MC/well)
ere counted with an ELIspot reader (Immunospot, CTL) to obtain
he number of isotype-speciﬁc ASCs per 5×106 MC.
.10. Statistical analysis
Statistical analysis (SPSS 11) of antibody titers and F4-speciﬁc
SC was done using General Linear Model (Repeated Measures
nalysis of Variance), adjusting for multiple comparisons by Bon-
eroni. p<0.05 was considered as statistically signiﬁcant.
. Results
.1. Mutations in faeGGIS26 reduce the F4 polymeric stability
The faeGGIS26 gene encoding the F4 ﬁmbrial adhesin and major
ubunit FaeG in the F4+ ETEC reference strain GIS26 was disrupted
ith a Cm-gene cassette to block the assembly of F4 ﬁmbriae
Fig. 1A). Replacement of faeGGIS26 with its Cm-disrupted coun-
erpart was conﬁrmed with DNA hybridization analysis to create
IS26faeG::Cm (Fig. 1B). Complementation of F4 biosynthesis in
IS26faeG::Cm with wild type faeG derived from GIS26 (pJJJ89) or
/95 (pJJJ92) ETEC strains resulted in a similar F4phenotype as their
ild type F4 counterparts. Indeed, when puriﬁed ﬁmbriae were
nalyzed on SDS-PAGE without heat treatment, F4GIS26 appeared





d4GIS26; 2, F45/95; 3, F4GIS26faeG::Cm , 4, F4GIS26faeG::Cm(pJJJ89); 5, F4GIS26faeG::Cm(pJJJ92); 6,
4GIS26faeG::Cm+(pHMM01), 7, F4GIS26faeG::Cm(pHMM02); and 8, F4 GIS26faeG::Cm(pHMM05).
Fig. 2). Puriﬁed F4GIS26 and F45/95 are both recognized in West-
rn blot (Fig. 3A) and ELISA (Fig. 3C) when using the FaeG-speciﬁc
Ab IMM01 that recognizes both FaeG monomers and polymers,
hereas only puriﬁed F4GIS26 are detected when using the FaeG-
peciﬁc MAb IMM09 that recognizes FaeG polymers only (Fig. 3B
nd D).
Point mutations were introduced to faeGGIS26 to analyze which
mino acids are involved in the reduced F4 polymeric stability of
45/95.Neither the changeof theFaeGGIS26 I201 toV (F4puriﬁed from
IS26faeG::Cm (pHMM01)) nor the FaeGGIS26 N97 to K (F4 puriﬁed
rom GIS26faeG::Cm (pHMM05)) had an inﬂuence on the F4GIS26
olymeric appearance on SDS-PAGE. However, when both muta-
ions (F4 puriﬁed from GIS26faeG::Cm (pHMM02); subsequently
eferred as F4pHMM02) were present, the mutant F4pHMM02 ﬁmbriae
ppeared only as FaeG monomers following SDS-PAGE since they
re only recognized by MAb IMM01 in Western blot (Fig. 3A and
). Surprisingly, F4pHMM02 was recognized in ELISA by both MAbs
MM01 and IMM09 (Fig. 3C and D). Electron microscopy conﬁrmed
he presence of polymeric structures in samples of F4GIS26 as well
s in samples of F4pHMM02 (Fig. 4). These results show that puriﬁed
4pHMM02 ﬁmbriae have retained a polymeric nature but that their
tability was reduced compared to the wild type F4GIS26 ﬁmbriae
ince the FaeG intersubunit interaction in F4pHMM02 ﬁmbriae was
roken during SDS-PAGE migration.
.2. Wild type F4 and mutant F4pHMM02 bind to the F4R
The capacity of puriﬁed F4GIS26 ﬁmbriae (stable polymers) and
4pHMM02 ﬁmbriae (unstable polymers) to bind the F4R was com-
ared since this binding is necessary for induction of an F4-speciﬁc
ntestinal immune response following oral immunization. The
esults from an in vitro inhibition adhesion assay showed that both
mbriae have the same F4R binding proﬁle, indicating that poly-
er stability of puriﬁed F4 does not signiﬁcantly inﬂuence binding
o the F4R in vitro (Fig. 5).
.3. Wild type F4 and mutant F4pHMM02 are resistant to
astro-intestinal breakdown
A second in vitro assay revealed that there was no inﬂuence
f the polymeric stability on its degradation in simulated gastric
onditions. Both stable (F4GIS26) and unstable (F4pHMM02) F4 poly-
ers survived the pepsin digestion at pH 2–4 (Fig. 6A), the pH
ondition of the stomach of weaned piglets [29]. They were only
egraded at pH1.5. F45/95 aremore susceptible to degradation since
egradation starts at pH 2. Incubation of F4GIS26 and F4pHMM02 in












mig. 3. Puriﬁed F4 ﬁmbriae separated by SDS-PAGE and detected by Western blot
entrations of puriﬁed F4 ﬁmbriae with the F4-speciﬁc MAb IMM01 (C) or IMM09
eat-denaturated F45/95; (4) non-heat denaturated F45/95; (5) heat-denaturated F4p
uminal content freshly isolated at different locations of the gastro-
ntestinal tract revealed only degradation of the ﬁmbriae when
resent in stomach content. Degradation was already observed for
oth ﬁmbriae following 30min incubation and was complete after
h (Fig. 6B and C). This experiment was performed with material
rom 3 animals and did not reveal differences in stability between




Fig. 4. Electron micrograph of puriﬁed F4pHMM02 ﬁmbriae (A) and F4GIS26 (B). The scathe FaeG-speciﬁc MAb IMM01 (A) or IMM09 (B) and interaction of different con-
n ELISA. Lane (1) heat-denaturated F4GIS26; (2) non-heat-denaturated F4GIS26; (3)
; (6) non-heat-denaturated F4pHMM02.
.4. Reduced polymeric stability of F4 ﬁmbriae reduces its
ucosal immunogenicityAsweobserved that stable F4polymers (F4GIS26) andunstable F4
olymers (F4pHMM02) have a similar receptor-binding capacity and
tability in gastro-intestinal conditions of newly weaned piglets,
hese ﬁmbriae could be used to analyze the inﬂuence of the poly-
le bar represents 50nm and the arrows are placed next to a ﬁmbrial structure.







































both F4 groups (p<0.02). Furthermore, IgA and IgG already peaked
F
a
3ig. 5. Percentage inhibition of F4+ ETEC adhesion to F4R+ intestinal villi by
oncentration-dependent binding of F4GIS26 or F4pHMM02 to the F4R.
eric stability of this soluble, non-replicating ﬁmbrial antigen on
ts in vivo mucosal immunogenicity. Newly weaned piglets were
rally immunizedwith F4GIS26 or F4pHMM02 or receivedPBSasnega-
ive control. Oneweek after immunization, the F4-speciﬁc immune
esponsewas analyzed in the intestinal tissues. Signiﬁcantly higher
umbers of F4-speciﬁc antibody secreting cells (ASC) were found
n the ileal Peyer’s patches (p≤0.046), mesenteric lymph nodes
p≤0.046) and the spleen (p=0.05) of F4GIS26 immunized than
BS animals (Fig. 7). F4pHMM02 immunized animals had only sig-
iﬁcantly higher IgM ASC in the spleen, in comparison to the PBS
nimals (54 versus 10, p=0.05). The number of IgA ASC was sig-
iﬁcantly higher in F4GIS26 immunized animals than in F4pHMM02





ig. 6. Stability of puriﬁed F4 ﬁmbriae in gastro-intestinal conditions. (A) Puriﬁed F4 ﬁm
native-PAGE and detected by Western blotting using anti-FaeG rabbit serum. Incubation
0, 60, 120 and 240min followed by detection of the ﬁmbriae in ELISA using the F4-speci6 (2008) 5728–5735 5733
eric lymph nodes. F4-speciﬁc IgA ASC were also detected in the
leal Peyer’s patches, peripheral blood and lamina propria, but
hese numbers were not signiﬁcantly higher than those for the
BS animals. Low numbers of F4-speciﬁc IgG ASC were observed
n peripheral blood, the spleen and mesenteric lymph nodes, but
here was no signiﬁcant difference between the groups. Further-
ore, F4-speciﬁc IgM and IgA could be detected 1 week following
ral immunization in the intestinal content of animals of the F4GIS26
roup (maximumIgMtiter 256 [n=2],maximumIgA titer 16 [n=1])
nd of the F4pHMM02 group (maximum IgM titer 4 [n=2],maximum
gA titer 2 [n=1]), but the highest levels were found in the F4GIS26
roup. In serum, a clear F4-speciﬁc IgA response was observed 1
eek after oral F4GIS26 immunization, but it was not signiﬁcantly
igher than the antibody levels in the other groups (Fig. 8). These
esults show a signiﬁcant intestinal immune response in F4GIS26
mmunized animals,whereas there is only aweakmucosal priming
n the F4pHMM02 immunized animals.
To conﬁrm priming of the F4-speciﬁc immune response in the
4pHMM02 immunized animals, all animals were intramuscularly
oosted with puriﬁed F4GIS26. Five days later, the F4-speciﬁc IgM
iter peaked in all 3 groups andwas slightly higher inboth F4groups
han in the PBS group (Fig. 8). However, at thatmoment IgA and IgG
ere also increasing in both F4 groups, whereas this was not the
ase in the PBS group resulting in a signiﬁcant higher IgG titer indays post secondary immunization (dpsi) whereas they were still
ncreasing 15dpsi in the PBS group. These data clearly show a sim-
lar secondary immune response in the F4 groups and a primary
ntibody response in the PBS group.
briae incubated in simulated gastric ﬂuid at pH 7, 4, 3, 2 and 1.5 were separated on
of puriﬁed F4GIS26 (B) and F4pHMM02 (C) in freshly isolated gastric content during 0,
ﬁc MAb IMM01.























































wig. 7. F4-speciﬁc ASC per 5×10 MC in blood (BL), mesenteric lymph nodes (MLN),
pleen (SP), ileal and jejunal Peyer’s patches (IPP and JPP) and lamina propria (LP)
f weaned piglets immunized with PBS (n=3), F4GIS26 (n=3) or F4pHMM02 (n=3) at 8
ays post immunization. Bars with different numbers differ signiﬁcantly (p<0.05).
. Discussion
The results of the present study show that a combination of two
mino acids that are different in FaeGGIS26 and FaeG5/95 inﬂuence
he F4 ﬁmbrial stability. Analysis of the sequence and protein fold
f FaeG revealed that the donor strand mechanism is involved in
he biogenesis of F4 ﬁmbriae [16,30]. Every ﬁmbrial subunit has
n immunoglobulin domain (Ig)-like fold lacking the C-terminal
-strand. The Ig-like structure is completed by inserting the N-
erminal donor strandof the subsequent subunit in theﬁmbria [31].
his mechanism creates stable ﬁmbriae with a tight interaction
etween subsequent subunits. Changing of amino acids asparagine
nd isoleucine at positions 97 and 201 in FaeGGIS26 to their FaeG5/95
ounterparts lysine and valine resulted in a reduced stability of F4
mbriae (F4pHMM02). The two changed amino acids are located out-
ide the conserved N- or C-terminal strands of FaeG what excludes
direct involvement in the donor strand mechanism. However, it
s likely that the combination of both amino acid changes affects
he global fold of the FaeG subunit and subsequently inﬂuences the
ubunit–subunit interaction since only monomers are detected in
DS-PAGE of puriﬁed mutant F4pHMM02 ﬁmbriae. The presence of
dditional amino acid changes in F45/95 will be necessary to further
odify its folding, increase its accessibility to proteases or facil-
tate pH-driven denaturation, which could explain the observed
nability of puriﬁed F45/95 to interact in ELISAwith theMAb IMM09
peciﬁc for F4 ﬁmbrial polymers and its reduced stability in gastro-
ntestinal conditions [24].
In most ﬁmbrial systems, the adhesin is located at the tip and
ontains a N-terminal lectin domain and a C-terminal pilin domain
ith an Ig-like folding connecting the lectin domain with the ﬁm-





aig. 8. Mean F4-speciﬁc IgM, IgA and IgG serum antibody titers (±S.E.M.) of weaned
iglets immunized with PBS, F4GIS26 or F4pHMM02. Black arrow, oral immunization;
hite arrow, intramuscular immunization (100g F4GIS26 in IFA).
ajor subunit and exists as one large domainwith an Ig-like folding
30]. Comparison of the amino acid sequences of the three different
4 serotypes and mutagenesis studies identiﬁed the regions con-
aining amino acids 162–171 of FaeG as putative receptor-binding
ite [15]. The receptor-binding site of FaeG is probably located at
he side of the domain [30] and would therefore be available in
ultiple positions throughout the F4 ﬁmbria. Evaluation of the in
itro binding of F4GIS26 and F4pHMM02 to F4R+ villi indicated that
ubstitution of both amino acids did not alter this binding. It was
ot expected that these amino acids would directly inﬂuence F4R
inding since they are not located in the putative receptor-binding
egion.
The results of the present study show that oral immunization of
eaned pigletswith F4pHMM02 could induce an F4-speciﬁc immune
esponse, but not as efﬁcient as following oral immunization
ith puriﬁed F4GIS26. This difference in mucosal immunogenicity
etween F4pHMM02 and F4GIS26 has to be related with their differ-
nce in polymer length stability since this was the only identiﬁed
actor differing between both ﬁmbriae. A similar resistance of both
mbriae in gastro-intestinal conditions suggests that both ﬁmbriae
ill reach the intestinal tract in an identical form.
It is not yet clear how the difference in polymeric stabilityesults in a different mucosal immunogenicity. Maybe the depoly-
erisation of F4pHMM02 ﬁmbriae is faster in comparison to F4GIS26
mbriae during transport of the ﬁmbriae to the intestinal immune
nduction sites. This means that the antigen dose taken up by
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mbriae than larger F4GIS26. On the other hand, there can be a faster
epolymerisationof F4pHMM02 ﬁmbriae thanF4GIS26 ﬁmbriae inside
ntigen presenting cells, which could inﬂuence intracellular sig-
alling. Cross-linking of receptors from antigen presenting cells is
eported to have an effect on the regulation of immune responses
33,34] and is more efﬁcient by molecules with a high polymeric
ature. The use of antigenic repeats is indeed a known method to
mprove the immunogenicity of an antigen [35,36].Wehave indica-
ions that incubation of porcine monocyte-derived dendritic cells
ith F4GIS26 ﬁmbriae is more effective to mature these cells than
4pHMM02, but this has to be further examined and will be part of
urther studies.
The obtained results show that the amino acids on position 97
nd 201 in F4 ﬁmbriae are important in the FaeG–FaeG interaction
nd consequently in theﬁmbrial polymeric character. Furthermore,
he polymeric character of the F4 ﬁmbriae is identiﬁed as one of the
actors responsible for its mucosal immunogenicity. This informa-
ion can be used to increase the mucosal immunogenicity of other
oluble non-replicating antigens and stimulate the development
f efﬁcient mucosal vaccines against human and animal infectious
iseases.
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